Funding provided by TerSera Therapeutics LLC. Content independently developed by OncLive.
May 12, 2022
Article
Treatment regimens that include ovarian suppression with a gonadotropin-releasing hormone agonist have gained momentum in recent years as a potential solution to address treatment-related early menopause for women with breast cancer.
May 12, 2022
Video
Lindsay L. Kroener, MD, discusses fertility preservation in patients with breast cancer.
May 11, 2022
Video
Matteo Lambertini, MD, discusses how GnRH agonists work to preserve ovarian function in premenopausal patients with breast cancer.
May 11, 2022
Video
Zaraq Khan, MBBS, discusses which patients with breast cancer would be ideal candidates to receive treatment with a GnRH agonist for ovarian protection.
May 10, 2022
Video
Kathryn Ruddy, MD, discusses the use of GnRH agonists in breast cancer.
May 06, 2022
Video
Ann H. Partridge, MD, MPH, discusses the utilization of GnRH agonists to preserve ovarian function in premenopausal patients with breast cancer.